Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of asenapine compared with an active control in adults with schizophrenia or schizoaffective disorder. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED